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Newly emerging health technologies are being developed to care for children with complex cardiac defects. Neurodevelopmental
andchildhoodschool-related outcomesare ofgreat interest to parents ofchildren receiving this care, careproviders, andhealthcare
administrators.Sincethe1970s,neonatalfollow-upclinicshaveprovided service,audit,andresearchforpreterm infantsascarefor
these at-risk children evolved. We have chosen to present for this issue the mechanism for longitudinalfollow-up of survivors that
we have developed for western Canada patterned after neonatal follow-up. Our program provides registration for young children
receiving complex cardiac surgery, heart transplantation, ventricular assist device support, and extracorporeal life support among
others. The program includes multidisciplinary assessments with appropriate neurodevelopmental intervention, active quality
improvement evaluations, and outcomes research. Through this mechanism, consistently high (96%) follow-up over two years is
maintained.2 Cardiology Research and Practice
1.Introduction
Neonatal and early childhood survivors of life-saving thera-
pies including complex cardiac surgery and heart transplan-
tation are at risk for neurodevelopmental sequelae. Possible
determinants are brain injury [1, 2], complications of early
gestational age birth or associated genetic abnormalities [3–
7], prolonged and recurrent hospitalizations [8], and in
some cases, a void of experiences available to other children
[9, 10]. The risk factors associated with adverse outcomesare
multifactorial [11–14]. Enhanced understanding isemerging
about patterns of health and neurodevelopmental outcome
with focus on cognition, attention, motor skills, behavior,
adaptive abilities, functional outcomes, health-related qual-
ity of life, and parental stress research [9, 10, 15–20]. This
valuable information can assist in counselling parents of
children needing speciﬁc procedures. In addition, combined
withdetailedacutecaredatabases,thisinformation caniden-
tify potentially modiﬁable predictors of outcome and evalu-
ate part or all of the systems of care for a given therapy [21].
For more than 30 years, neonatal follow-up clinics have
providedmultidisciplinaryassessments ofhigh-risk neonates
[22]. These clinics have the framework, experience, and
expertise tocompletelong-termfollow-up ofat-risk children
[23]. Most neonatal follow-up clinicsprovide neurodevelop-
mental assessments and have a mission of service to the child
and family, as well as audit and research. Such service may
be initiated by the program or through appropriate referrals.
Individualized intervention may include nutritional ther-
apy, physical therapy, occupational therapy, speech-language
therapy, assessment and treatment of hearing loss, psycho-
logical interventions, social work support, and/or medical
treatments. Group developmental intervention programs
may be community based or tertiary care based. Key to
the work of a neonatal follow-up clinic is the mission of
audit [22]. Neurodevelopmental morbidity outcomes are
linked to acute care variables to provide a basis for quality
improvement as well as population trends. Various types
of research facilitated through neonatal follow-up clinics
include speciﬁc, local, and multicentered outcome studies
as well as multicentered randomized controlled trials [22].
These clinics provide a setting for teaching trainees and
interaction among all disciplines interested in the welfare
of the high-risk infant [22]. Neonatal follow-up clinics are
closely linked to neonatal intensive care but may be located
in general or pediatric hospitals, or rehabilitation facilities.
Many neonatal follow-up clinics now have extended entry
criteria to include ill neonates beyond preterm children and
some see children whose therapy occurred after the neonatal
period [21]. Assessment guidelines for high-risk neonates
have been published [24, 25].
This paper presents the organization of the Registry
and Follow-up of Complex Pediatric Therapies Program of
Western Canada which is based on the neonatal follow-up
clinic model. This registry has been successful in the follow-
up of infants and young children surviving life-threatening
illnesses treated with newly emerging health technologies,
identifyingmodiﬁable variablesateachlevelofcare,building
a quality improvement program, and publishing outcomes
research while providing a range of services for survivors
with neurodevelopmental sequelae.
2.Methods
This is an interprovincial longitudinal neurodevelopmental
follow-up program that began in 1999 for children from the
western provinces of Canada and corresponding northern
territories who have had invasive complex therapies in
Alberta, Canada. The majority of proceduresincluding com-
plex cardiac surgery are done at the Stollery Children’s Hos-
pital,Edmonton,Alberta,Canada.Theprogramevolvedover
the period from 1996 to 1999 beginning with a specif-ic
research study on neurodevelopmental follow-up after com-
plex cardiac surgery done at ≤6 weeks of age and published
in 2004 [26].
2.1. Organization. Program members include representa-
tivesofacutecare departmentsincluding,cardiology,cardio-
vascular surgery, nephrology, hepatology/gastroenterology,
and neonatal and pediatric intensive care in the province of
Alberta as well as members from these specialities from par-
ticipating sites across western Canada. Follow-up occurs at
six sites. Follow-up team members including paediatricians
with expertise in neurodevelopmental follow-up, psycholo-
gists, and audiologists are part of the membership. There is
a direct liaison with healthcare administration at each site.
A steering committee consists of the cochairs (a neurode-
velopmental pediatrician, pediatric intensivist, and neona-
tal developmental follow-up/intensivist) and membership
from the acute care departments. There are three standing
subcommittees within the steering committee: data entry,
retrieval, and linkage; outcome measurements; evaluation.
Enrolment criteria are determined through the work of the
core steering committee and individual departments.
Following a research study from 1996 to 1999 [26], a
project grant was obtained from the provincial government
for the period from 1999 to 2006 to determine healthcare
outcomesofemergingtechnologies. Since2006,theprogram
has been part of the global budget at all sites to varying
degrees with respective accountability.
3.Procedure
Referrals for follow-up are made by the attending physician
within each acute care department based on predetermined
entry criteria. Once survival is deemed likely, a nurse coordi-
nator registers the child and discusses follow-up procedures
with the parents. As parents become involved in the follow-
up registration process, they come to understand the dual
purpose of follow-up to include service for possible devel-
opmental concerns for their child and parental psychosocial
support as well as an audit of outcomes of new complex
therapies. Contact is made with the follow-up clinic at the
tertiary site of origin. The project is approved by local health
research ethics boards. All parents/guardians sign informed
consent for follow-up and participation in the database.Cardiology Research and Practice 3
Databases were established for children needing each of
the listed therapies. Acute care variables were chosen and
modiﬁed by the cochairs and representatives of each depart-
ment, and data are recorded prospectively by a program
assistant. Outcome variables are standardized age appropri-
ate,anduniform atallsites. Oncecompiled,anonymous data
are returned to the central site for checking with a hard copy
of the assessment results and for keying. All data entry is
checked by one of the cochairs. SPSS, version 17, is currently
used for datastorage and SPSS and SASare used for analyses.
3.1. Assessments. At hospital discharge, we record speciﬁc
acute measures and any underlying conditions that may
ultimately aﬀect the outcome of the child. Birth head
circumference and head circumference at discharge are
recorded as has been previously published for children
after hypoxic-ischemic encephalopathy [27]. Information
on genetic abnormalities or dysmorphic features, antenatal
infections, and maternal substance abuse are recorded. Any
available cranial imaging information is recorded as has
been recommended [28]. Birth prevalence for the various
defects may vary by year, location, race, and socioeconomic
levels [29] thus information on year, locale, race [30], and
socioeconomic levels [31]a r ec o m p l e t e d .
Prior to the ﬁrst follow-up assessment, records con-
cerning the visual awareness of the child, including oph-
thalmological reports, formal hearing test results as have
been recommended for at-risk children, [32] and recorded
observations of feeding and swallowing by an experienced
nurse or therapist are obtained. The latter includes speciﬁc
concerns for airway anomalies in children with congenital
heart disease which may subsequently interfere with the
child’s health and development [33]; information on facial
hypotonia, a common diﬃculty for ill children, often
addressed with positioning and feeding suggestions; inco-
ordination or absent swallowing requiring alternate feeding
methods with sensory lip and mouth stimulation by a
feeding therapist [34]. Any concerns about the vulnerable
child syndrome and its consequences for the child’s social,
emotional, and behavioural growth are recorded [35].
3.2. Measures. Timelines and approach to the long-term
follow-up are similar to published guidelines [24, 25].
Measures include assessment, rating, or screening tools. The
focus of the assessment at each age is to assist in providing
service for children to reduce impact on limitations of
function, activities, and participation asrecommended using
the WHO International Classiﬁcation of Function [36].
Outcome measures are standardized, and the latest edition
is used. Overall, test batteries appropriate for age measure
neurodevelopment,intellectual function, attention, memory
and learning, language, behavior, motor function, and
hearing, as well as neurological examination (Table 1).
4.StatisticalAnalysis
Kaplan-Meier survival curves with log-rank test are used to
compare cumulative survival across several groups. Contin-
uous outcomes of morbidity are presented as means (SD);
categoricalvariables arepresented as countsand percentages.
To screen for variables associated with outcomes, univariate
regression models are used. Multiple regression models are
built based on variables signiﬁcant at P<. 10 in the
corresponding univariate analysis, and after screening for
multicollinearity. The type of outcome drives the choice
of the regression model and presentation of results, for
example, linear regression is used for continuous outcomes
and results are presented as eﬀect sizes, logistic regression is
used for dichotomous variables and results are presented as
odds ratios, and the Cox proportional hazard model is used
for survival data, and results are presented as hazard ratios.
Allestimates are presentedtogetherwithconﬁdenceintervals
and two-sided P values.
When testing several outcomes, one should adjust for
multiple comparisons. The larger the number of outcomes
tested, the more inﬂated the Type I error. Bonferroni type
adjustments are made in such situations.
5.Results
Since 1996, over 1000 children have been registered with
thisfollow-up program.This includes659children following
complex cardiac surgery done at age ≤ 6 weeks (Table 2), 11
children after chronic renal dialysis in the ﬁrst year of life,
175 children after solid organ transplantation done at age
5 years or less (61 heart, 97 liver, 17 kidney), 153 children
after extracorporeal life support given at age 5 years or less
(109 cardiac, 44 pulmonary), 21 children with ventricular
assist devices at age 5 years or less, and 16 children following
coolingafterin-hospitalcardiopulmonaryresuscitationdone
at age 5 years or less. Follow-up at two years is >96%
(Figure 1).
5.1. Service. The Registry and Follow-up of Complex Pedi-
atric Therapies Program has beneﬁted children receiving
emerging health technologies in our region. Assessments
and interventions can make a signiﬁcant improvement in
the child’s ultimate quality of life [52, 53]. With early
recognition of developmental delay and family support to
promote the child’s motivation and learning, the child’s
long-term outcome is improved. There are few children
undergoing these rare-event therapies: in our region, they
would typically not receive early intervention and early
education without the follow-up clinic outcome assessments
directing the family to the appropriate program (Table 3).
Our follow-up program has a strong advocacy role for
children and provides an added value service to the child
and family while obtaining outcome data. The educational
system beneﬁts from having the children more prepared for
learning at school entry and having knowledgeaboutspeciﬁc
learning patterns of the survivors.
Knowledge of the risk, safety, and outcome of care for
life-threatening illness enablesacutecare practitionerstodis-
cuss, from a stronger evidence base, the potential outcomes
for children undergoing these therapies. Parents become
more familiar with the process and begin to understand the
life-saving procedures as only one step in the overall system4 Cardiology Research and Practice
Table 1: Disciplines that assess and measures used for neurodevelopmental and neurocognitive follow-up after complex cardiac surgery at
≤6 weeks of age.
Follow-up age Disciplines
assessing Speciﬁc tests required for outcomes
6t o8m o n t h sa f t e r
surgery/therapy
Physical therapist∗
Audiologist∗∗
Physician/nurse∗∗∗
18 to 24 months
(range 18–36 months)
Psychologist
Audiologist∗∗
Speech-language
pathologist∗
Physician/nurse∗∗∗
Bayley Scales of Infant and Toddler Development—3rd Edition. All
components include Cognitive Scale, Language Scale (receptive and expressive
language), Motor Scale (ﬁne and gross motor), Social-Emotional Scale, and
Adaptive Behavior Scale [37].
Child Behavior Checklist with Language
Development Survey [38].
4.3 to 5.5 years
(range 4–6 years)
Psychologist
Audiologist∗∗
Speech-language
pathologist
Physician/nurse∗∗∗
Wechsler Preschool and Primary Scale of Intelligence—3rd Edition [39].
Visual Motor Integration—5th Edition [40].
Behavior AssessmentSystem for Children—2nd Edition [41].
Adaptive-Behavior Assessment System—2nd Edition [42].
Pediatric Quality of Life Inventory, Generic Core Scales [43], and Cardiac
Module [44].
Clinical Evaluation of Language Fundamentals—2nd Edition [45].
8y e a r s± 6m o n t h s( r a n g e
6.5 years to 16y 11 months)
selectively for children with
single ventricle defects,
heart transplantation,
extracorporeal membrane
oxygenation
Psychologist
Audiologist∗∗
Physician/Nurse∗∗∗
Wechsler Intelligence Scale for Children—4th Edition [46].
Visual Motor Integration—5th Edition [40].
Wechsler Individual Achievement Test—2nd Edition [47].
NEPSY—2nd Edition [48].
Adaptive Behavior Assessment System—2nd Edition [42].
Behavior Rating Inventory of Executive Function Parent Form [49].
Child and Adolescent Scale of Participation [50].
Strength and Diﬃculties Questionnaire [51].
Pediatric Quality of Life Inventory, Generic Core Scales [43].
∗Clinicalassessment,no data collection. Measures individually determined.
∗∗Standard audiological assessmentfor at-risk children [32].
∗∗∗At each visit, the pediatrician and nurse complete a predetermined questionnaire about illnesses and hospitalizations as well as diet, feeding, sleep,
immunizations, and parent support; record growth; complete a general and neurological examination. If required, other disciplines such as occupational
therapist,dietician, or social worker assessesthe child/family.
Table 2: Type of complex cardiac surgery at ≤6 weeks of age in relation to grouped years of surgery: 1996–2010.
Years Total ASO Norwood for HLHS TAPVC Other
n = 659 n = 188 n = 146 n = 81 n = 244
1996–1999 92 (14%) 28 (15%) 25 (17%) 9 (11%) 30 (12%) (9 ca)
2000–2002 119 (18%) 35 (19%) 36 (25%) (2 ca) 19 (23%) (1 ca) 29 (12%) (7 ca)
2003–2005 149 (22%) 51 (27%) 31 (21%) (1 ca) 20 (25%) 47 (19%) (14 ca)
2006–2008 156 (24%) 42 (22%) 34 (23%) 20 (25%) 60 (25%) (11 ca)
2009-2010 143 (22%) 32 (17%) (1 ca) 20 (14%) 13 (16%) 78 (32%) (7 ca)
ASO = arterial switch operation.
HLHS = hypoplastic left heart syndrome.
TAPVC = total anomalous pulmonary venous correction.
ca = chromosomal abnormalities.
Other by primary defect = pulmonary atresia, 52; interrupted aortic arch, 36; tetralogy of fallot, 34; truncus arteriosus, 32; double outlet right ventricle, 24;
hypoplastic aortic Arch, 14; AV canal, 14; tricuspid atresia, 10; Other, 28.
Note: 52 (7.9%) of 659 had chromosomal abnormalities.
of care. They become more knowledgeable regarding their
child and have increased willingness for their child to beneﬁt
from early interventionand educational experiences. Parents
areempoweredtoplayastrongeradvocacyrolefortheirchild
to achieve the best outcome.
5.2. Quality Improvement/Research. Functional information
from the Adaptive Behavioral Assessment System, second
edition [42] ,h e l p su st og i v ead e s c r i p t i o no ft h ee x t e n ta n d
range of functional limitations that children after complex
cardiac surgery experience as they grow. This informationCardiology Research and Practice 5
Died before hosp d/c
51 (7.7%)
Survived to hosp d/c
608 (92.3%)
Eligible to be followed to age 2∗
469
Died before age 2
45 (9.6%)
Survived to age 2
424 (90.4%)
Assessed at age 2
410 (96.7%)
Not assessed at age 2
14 (3.3%)
Eligible to be followed to age 5∗
292
Died before age 5
5 (1.7%)
Survived to age 5
287 (98.3%)
Assessed at age 5
272 (94.8%)
Not assessed at age 5
15 (5.2%)
∗139 children have not yet reached age 2, and 132 children have not yet reached age 5.
659
Registered in 1996–2010
Figure 1: Flowchart of death, lost, and assessed children after complex cardiac surgery at ≤6 weeks of age from the year 1996 to 2010;
inclusive. hosp d/c = discharge from hospital where surgery took place.
allows a proactive and dynamic approach to preparing
parents with the challenges of raising children who have
been very ill and gear interventions toward individual needs
(Table 3).
Modiﬁcations in the type of assessments we administer
and the focus of counselling have evolved based on our
results (Table 3). In some cases, these results may not be
generalizable but apply to our populations. By grouping
outcome data and analyzing predictor acute care variables,
we have identiﬁed potentially modiﬁable variables resulting
in speciﬁc quality improvement evaluations (examples are
provided in Table 3).
Our program has contributed to the outcomes literature
following complexcardiac surgery forvery young children in
an u m b e ro fw a y s( T a b l e s4–7). Serial lactate determination
has been shown to predict survival [64]. Building on our
early study [26], we completed a longitudinal study and con-
ﬁrmed that neurodevelopmental outcomes at two years of
age for children after complex cardiac surgery are predictive
of the neurocognitive outcomes at age ﬁve years [65]. The
sensitivity and speciﬁcity of the mental developmental index
scoresunder85 forpredicting the full-scale intelligencescore
at preschool were 85.7% and 89.7%, respectively, indicating
the value of testing children at younger ages.
We have published on the early childhood outcome fol-
lowing total anomalous pulmonary venous correction [60].
As an unexpected ﬁnding, we found that aboriginal children
were markedly over represented in this group compared
with the rest of our population. We have also published
on the outcomes of children with interrupted aortic arch
without chromosomal anomalies [66]a n dc h i l d r e nw i t h
complex cardiac surgery in the neonatal period who have
deletion 22q11.2 [7]. The latter are at a high risk for adverse
neurodevelopmental outcomes. A recent paper of the two-
yearneurodevelopmentaloutcomesofchildren following the
Norwood right ventricle-to-pulmonary artery shunt surgical
repair demonstrated improved survival and psychomotor
developmental outcome over the previous Blalock-Taussig
surgical era [58].
The ﬁndings of the follow-up program have justiﬁed
the investment in several ways. We are one of few groups
to describe the long-term neurodevelopmental outcome
and general morbidity of many groups of cardiac diseases
treated in the neonatal period (Tables 4 and 7). We have6 Cardiology Research and Practice
Table 3: Examples of audit and research ﬁndings resulting in changes in care for survivors following complex cardiac surgery at ≤6 weeks
of age.
Service delivery Audit funding Changes in care
General areas
Timely access to therapy
Assessments by physical therapists, occupational
therapist, dieticians and speech-language
pathologists provided evidence of the needs of
survivors to site managers and to attending
physicians.
Therapy and early developmental intervention as
needed is available from time of hospital
discharge at each site.
Children’s attending physicians are more aware of
the developmental needs of survivors and the
importance and beneﬁt of early developmental
intervention.
Enhancement of
multidisciplinary
assessmentclinics
Therapists demonstrated the beneﬁts of
multidisciplinary assessments of survivors to their
managers.
Funding for follow-up clinics has become part of
the global budget for 4 of the 6 sites.
Identiﬁcation of areas for
focused developmental
intervention.
Team assessmentsidentiﬁed speciﬁc areas of
developmental concerns.
Monitoring and developmental therapy
interventions have become proactive and more
focused to the speciﬁc needs of the child and
family.
Education and advocacy for developmental
community supports have resulted in improved
services for children and families.
Speciﬁc neurodevelopmental areas
Functional development Delays have been demonstrated [10].
Involvement of our program staﬀ with bedside
developmental care, discharge planning, early
developmental intervention, and parent
education.
Speech-language
development
Language delay was noted after arterial-switch
operation [54]. A high proportion of all survivors
were noted to have delay on the vocabulary score
of the Language Developmental Survey of the
Child Behaviour Checklist [38]( u n p u b l i s h e d
data).
All survivors after early cardiac complex surgery
are now assessed by a speech-language pathologist
at the 2-year visit.
Social communication Impairments were shown after arterial-switch
operation [55].
Children are monitored during the preschool
period for language and social communication
skills. Intervention is started as needed.
Preschool behaviour For our survivors, behavioural concerns do not
e x c e e dt h o s ei nt h en o r m a t i v ep o p u l a t i o n[ 56].
Counselling avoids suggestions of possible future
adverse behaviour as this can become a
self-fulﬁlling prophecy.
Cerebral palsy This is not a common complication among our
survivors [57].
Counselling at the time of surgery based on
imaging suggests monitoring without predicting
cerebral palsy.
Gross motor abilities Delays have been demonstrated [58]. Clinic plan to add a standardized motor measure
[59].
Pulmonary complications Common following total anomalous pulmonary
venous correction [60].
Consideration of additional routine referrals for
pulmonary consultation.
Speciﬁc acute care areas
Mean arterial pressure after
re-warming in the
operating room
Lower mean arterial pressure was associated with
death [61].
Blood pressure control in the operating room has
been changed.
Transfusion in neonates
undergoing the Norwood
operation
Transfusion did not improve outcomes [62]. Transfusion practices have been altered.
Extracorporeal life support Time for lactate to fall and inotrope score are
associated with outcome [63].
There is increased focus on the optimal cannula
size and initial blood ﬂow rates when patients are
placed on extracorporeal life support.Cardiology Research and Practice 7
Table 4: Selected outcomes of neonates having complex cardiac surgery for congenital heart disease followed by the Complex Pediatric
Therapies Follow-up Program.
Group (years, n) 2-year survival MDI (mean, SD) PDI (mean, SD)
ASO (1996–2004; n = 88) [54] 99% 89 (17) 92 (15)
TAPVC (1996–2004; n = 32) [60] 97% 87 (16) 89 (13)
Norwood MBTS (1996–2002; n = 62) [58] 48% 79 (18) 67 (19)
Norwood RVPA (2002–2005; n = 32) [58] 81% 85 (18) 78 (18)
IAA (1996–2006; n = 27) [66] 96.5% 76 (17) 72 (17)
Deletion22q11.2 (1996–2004; n = 16) [7] 81% 66 (11) 55 (9)
Cardiac ECLS (2002–2004; n = 39) [63] 41% 73 (16) —
E-CPR subgroup (n = 9) 33% — —
Heart transplant under age 6yr (1999–2006; n = 33) [67] 88% Delay 34% Delay 52%
ASO: arterialswitchoperationfortranspositionofthe great arteries;TAPVC: totalanomalouspulmonary venous correction; MBTS:modiﬁed Blalock-Taussig
shunt; RVPA: right ventricle-to-pulmonary artery shunt; IAA: correction of interrupted aortic arch; ECLS: extracorporeal life support; E-CPR: ECLS started
during ongoing chest compressions for refractory cardiac arrest; MDI: Mental Developmental Index; PDI: Psychomotor Developmental Index.
Table 5:Variablesfoundassociatedwithoutcomesofspeciﬁcgroupsofneonateshavingcomplexcardiacsurgeryforcongenitalheartdisease
followed by the Complex Pediatric Therapies Follow-up Program.∗
Group (years, n) Associated with survival Associated with MDI Associated with PDI
ASO (1996–2004; n = 88) [54]— EGA, preoperative lactate and days ventilated,d a y si nh o s p i t a l
ASO (1996–2003; n = 65;
5-year outcomes of FSIQ) [55] — Mother’s years of schooling, EGA, postoperative d1 lactate
TAPVC (1996–2004; n = 32)
[60] —S E S Weight at surgery,
postoperative d1 lactate
Norwood MBTS (1996–2002;
n = 62) [58]
Postoperative d2-5 lactate
and base deﬁcit SES, hospital days Sex
Norwood RVPA (2002–2005;
n = 32) [58] Postoperative d2-5 lactate
Preoperative Pa02 and
days ventilated,D H C A
time
CPR anytime, hospital
days
Norwood (1996–2005, no
ECLS, n = 82) [62]
Postoperative d2-5 nadir
haemoglobin level
First postoperative day
of negative ﬂuid balance
Sex, ﬁrst postoperative
day of negative ﬂuid
balance
IAA (1996–2006; n = 27) [66]—
Chromosomal
abnormality, Apgar
score, DHCA used
Chromosomal
abnormality
Cardiac ECLS (2002–2004;
n = 39) [63]
Single ventricle, lactate
on admission,days
ventilated
Chromosomal
abnormality, time for
lactate to fall on ECLS,
highest inotrope score ﬁrst
5d on ECLS
—
Heart transplant (1999–2006;
n = 33) [67] Congenital heart disease Congenital heart disease Congenital heart disease
ASO: arterial switch operation for transposition of the great arteries; TAPVC: total anomalous pulmonary venous correction; MBTS: modiﬁed Blalock-
Taussig shunt; RVPA: right ventricle-to-pulmonary artery shunt; IAA: correction of interrupted aortic arch; ECLS: extracorporeal life support; E-CPR: ECLS
started during ongoing chest compressions for refractory cardiac arrest; EGA: early gestational age; MDI: Mental Developmental Index; PDI: Psychomotor
Developmental Index; ∗Variables that are potentially modiﬁable are in italicizedfont.
found several potentially modiﬁable acute care variables
with the potential to improve outcomes of these neonates
with each cardiac disease (Table 5). In addition, we have
beenabletoexamine speciﬁcpotentiallymodiﬁable variables
that have been of great interest in the literature, including
blood pressure, transfusions, lactate, sedation, and CPR,
for their association with outcome (Table 6). These ﬁndings
have led to improved counselling of parents, improved
long-term care, and changes in acute care that have great
p o t e n t i a lt oi m p r o v eo u t c o m e s( Table 3). Continued follow-
up informs whether these outcomes are improving over
time; for example, we found that the outcome of HLHS
childrenhasimprovedsigniﬁcantlybetweentwosurgicaleras
[58].8 Cardiology Research and Practice
Table 6: Some speciﬁc variables examined for association with outcomes of neonates having complex cardiac surgery for congenital heart
disease followed by the Complex Pediatric Therapies Follow-up Program.
Variable examined (years, n)E ﬀect on outcomes
Postoperative lactate (1996–1999; n = 85) [64] Associated with mortality; lactate ≥ 7mmol/L on admission,
and d1 peak ≥ 8mmol/L:sensitivity 83%, speciﬁcity 82%.
MAP after re-warming in the operating room (1996–1999;
n = 70) [61]
Associated with mortality by 5 years of age: minutes MAP ≤
30mmHg odds ratio 1.09 (95% CI 1.03, 1.16).
Transfusion in Norwood Group (1996–2005; n = 82) [62] Associated with ventilator days postoperatively: postoperative
number of transfusions d2-5 eﬀect size 1.85 (0.33, 3.36) days.
Postoperative CPR (1996–2005; n = 29) [68] Associated with mortality by 2 years (odds ratio 15.02, 95% CI
4.63, 48.76), but not neurodevelopmental outcome in survivors.
Perioperative sedation (benzodiazepines, opiates, chloral hydrate,
ketamine, inhalationalagents; 2003–2006; n = 95) [69]
No evidence of an association with neurodevelopmental
outcomes.
Deletion 22q11.2 (1996–2004; n = 16) [7] Associated with MDI and PDI.
MAP: mean arterial pressure: CPR: cardiopulmonary resuscitation;MDI: Mental Developmental Index; PDI: Psychomotor Developmental Index.
Table 7: Selected outcomes of neonates having complex cardiac surgery for congenital heart disease followed by the Complex Pediatric
Therapies Follow-up Program.
Group (years, n)M i c r o c e p h a l y W e i g h t <5th percentile Height<5th percentile Cerebral palsy
ASO (1996–2004; n = 88) [54] 1.5% 6.1% 9.8% 1.2%
TAPVC (1996-2004; n = 32) [60]0 % 3 % 0 % 0 %
Norwood MBTS (1996–2002; n = 62) [58] 7% 17% 20% 0%
Norwood RVPA (2002–2005; n = 32) [58] 0% 27% 12% 4%
IAA (1996–2006; n = 27) [66] 7.7% 19% 19% —
Deletion 22q11.2 (1996–2004; n = 16) [7] 15% 8% 31% —
Cardiac ECLS (2002–2004; n = 39) [63] 20% 19% 13% 13%
Heart transplant under age 6yr (1999–2006; n = 29) [67] — 28% 31% 10%
ASO: arterialswitchoperationfortranspositionofthe great arteries;TAPVC: totalanomalouspulmonary venous correction; MBTS:modiﬁed Blalock-Taussig
shunt; RVPA: right ventricle-to-pulmonary artery shunt; IAA: correction of interrupted aortic arch; ECLS: extracorporeal life support.
6.Discussion
We have chosen to present the organization of the Registry
and Follow-up of Complex Pediatric Therapies Program to
demonstrate a mechanism for longitudinal follow-up. Using
the model of neonatal follow-up clinics, we have established
a longitudinal follow-up program in western Canada for
children receiving new and emerging therapies in Alberta
and particularly for those receiving complex cardiac surgery
as very young children at the Stollery Children’s Hospital in
Edmonton. By linking with the neonatal follow-up clinics,
we have been able to use their expertise to maintain a
high proportion of follow-up and establish an ongoing
and interactive database. This database has been valuable
to establish quality improvement studies and outcomes
research as has been recommended [70].
Several areas of change have been initiated as a result
of the ﬁndings of our follow-up program (detailed in
Table 3). Examples in general areas include improved timely
access to developmental intervention, enhanced funding for
demonstrably needed multidisciplinary assessment clinics,
and improved proactive advocacy for these children. Exam-
ples in speciﬁc areas include: improved early intervention
and parent education regarding impaired functional devel-
opment, standard speech-language pathologist assessment,
and monitoring for language and social communication
skills. Examples in acute care areas include: improved blood
pressure control in the operating room, altered transfusion
practices in single ventricle neonates, and improved man-
agement of neonates requiring extracorporeal life support.
Ongoingfollow-upwill identifyifthesequalityimprovement
interventions have been associated with improved outcomes
in these neonates. In addition, the data from our follow-up
group is now being used to inform design of prospective
randomized trials of interventions.
We believe the key to the work we have done is based
on the interaction between service for the child and family
and the study of outcomes. This provides an opportunity
to enhance the quality of care that we, as healthcare
professionals, provide and enables us to minimize secondary
developmental disabilities.
This longitudinal follow-up program is now established
as part of the care of new and emerging therapies in
Alberta and for children transferred to this province for
this care. We are very grateful to the hospitals, clinics,
and parents who cooperate to make this possible. OurCardiology Research and Practice 9
attrition rate is low, under 4% over 2 years, and similar
to other follow-up programs in western Canada. We have
documented outcomesto aid in the counselling of parents of
newly referred children needing these therapies. Some novel
ﬁndings have been reported. Potentially modiﬁable variables
have been identiﬁed that can inﬂuence acute care practices.
Most importantly, we are providing a needed service to the
children following these life-saving therapies.
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